U.K. mulls R&D tax credits for midsize biotechs

12/3/2004 | Reuters

The U.K.'s chancellor of the exchequer says he intends to review a tax credit given to medium-sized biotech and drug companies for research and development with an eye to increasing them as a way to encourage the industry. Gordon Brown also said he would end tax barriers that block spin-off companies created by universities. The drug industry applauded the promised move.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC